Hot Life Science Investor Mandate 3: Large Taiwanese VC Fund Seeking Novel Therapeutics and Devices throughout Taiwan, China, Europe and the U.S.

5 Feb

A venture capital firm based in Taiwan has USD 2.5 billion AUM and invests in companies of all stages, from early, expansion, to maturity stage. The firm invests in several sectors including healthcare. Currently, the firm is looking for investment opportunities with an exit timeline of 3-5 years. The firm is most interested in companies that are ready for IPO or M&A. The investment size varies depending on the stage of the company. The firm can allocate as USD 1 million up to USD 20 million or more, the firm invests in companies that are located in China, Taiwan, US, and Europe.

In healthcare, the firm is currently most interested in therapeutics. The firm is also looking at medical devices. For therapeutics, the firm looks for novel compounds and biologics that are either first-in-class or best-in-class. The firm is indication agnostic. In terms of stage of development, the firm is open as long as there is a concrete plan for an exit timeline of 3-5 years. For medical devices, the firm is generally opportunistic. The firm seeks devices that are innovative and disruptive.

The firm can both lead and co-invest with a syndicate. The firm generally request board of director’s representation following investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: